Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Evangelos N Liberopoulos, Matilda Florentin, Dimitri P Mikhailidis & Moses S Elisaf. (2008) Compliance with lipid-lowering therapy and its impact on cardiovascular morbidity and mortality. Expert Opinion on Drug Safety 7:6, pages 717-725.
Read now
Read now
M. Florentin, E. N. Liberopoulos, D. P. Mikhailidis & M. S. Elisaf. (2008) Colesevelam hydrochloride in clinical practice: a new approach in the treatment of hypercholesterolaemia. Current Medical Research and Opinion 24:4, pages 995-1009.
Read now
Read now
Katherine Anagnostopoulou, Genovefa Kolovou, Peggy Kostakou, Constantinos Mihas, Dimitri Mikhailidis & Dennis V Cokkinos. (2007) Pharmacogenetic study of cholesteryl ester transfer protein gene and simvastatin treatment in hypercholesterolaemic subjects. Expert Opinion on Pharmacotherapy 8:15, pages 2459-2463.
Read now
Read now
B. ilerigelen, Y. Üresin, M. Şan, H. KÜltÜrsay, S. GÜneri, O. A. Serdar, S. GÜleç & H. Pençedemir. (2007) Efficacy and safety of extended-release fluvastatin in Turkish patients with hypercholesterolaemia: TULiPS (Turkish Lipid Study). Current Medical Research and Opinion 23:5, pages 1093-1102.
Read now
Read now
Ranjababu Kulasegaram, Barry S. Peters & Anthony S. Wierzbicki. (2005) Dyslipidaemia and cardiovascular risk in HIV infection. Current Medical Research and Opinion 21:11, pages 1717-1725.
Read now
Read now
Articles from other publishers (22)
Mariacristina Nicolosi, Francesco Bellia, Maria Laura Giuffrida, Stefania Zimbone, Valentina Oliveri & Graziella Vecchio. (2021) Synthesis and biological evaluation of novel β-cyclodextrin-fluvastatin conjugates. Results in Chemistry 3, pages 100230.
Crossref
Crossref
Yijiang Li, Jens Gottlieb, Donghui Ma, Christian Kuehn, Martin Strueber, Tobias Welte, André R. Simon, Georg Warnecke & Axel Haverich. (2011) Graft-Protective Effects of the HMG-CoA Reductase Inhibitor Pravastatin After Lung Transplantation— A Propensity Score Analysis With 23 Years of Follow-Up. Transplantation 92:4, pages 486-492.
Crossref
Crossref
Mojca Lunder, Miodrag Janić, Sara Habjan & Mišo Šabovič. (2011) Subtherapeutic, low-dose fluvastatin improves functional and morphological arterial wall properties in apparently healthy, middle-aged males – a pilot study. Atherosclerosis 215:2, pages 446-451.
Crossref
Crossref
Seung Don BaekSun-Joo JangSo-Eun ParkTae Jin OkJaechan LeemHo-Su LeeSo Jung ParkTae Hee Kim. (2011) Fatal Rhabdomyolysis in a Patient with Liver Cirrhosis after Switching from Simvastatin to Fluvastatin. Journal of Korean Medical Science 26:12, pages 1634.
Crossref
Crossref
Minoru Hongo, Setsuo Kumazaki, Atsushi Izawa, Hiroya Hidaka, Takeshi Tomita, Yoshikazu Yazaki, Osamu Kinoshita & Uichi Ikeda. (2011) Low-Dose Rosuvastatin Improves Arterial Stiffness in High-Risk Japanese Patients With Dyslipdemia in a Primary Prevention Group. Circulation Journal 75:11, pages 2660-2667.
Crossref
Crossref
Genovefa Kolovou, Constantinos Mihas, Katherine Anagnostopoulou, Vana Kolovou, Vasiliki Giannakopoulou, Peggy Kostakou, Marianna Stamatelatou, Sophie Mavrogeni, Dimitrios Degiannis & Dimitri P. Mikhailidis. (2010) Cholesteryl Ester Transfer Protein Gene and Effectiveness of Lipid Lowering of Atorvastatin. The Open Cardiovascular Medicine Journal 4:1, pages 297-301.
Crossref
Crossref
Mehmet Ozaydin, Yasin Turker, Dogan Erdogan, Mustafa Karabacak, Abdullah Dogan, Ercan Varol, Emel Gonul & Ahmet Altinbas. (2010) The association between previous statin use and development of atrial fibrillation in patients presenting with acute coronary syndrome. International Journal of Cardiology 141:2, pages 147-150.
Crossref
Crossref
Michael S. Kostapanos, Haralampos J. Milionis & Moses S. Elisaf. (2008) An Overview of the Extra-Lipid Effects of Rosuvastatin. Journal of Cardiovascular Pharmacology and Therapeutics 13:3, pages 157-174.
Crossref
Crossref
Theodosios D. Filippatos & Dimitri P. Mikhailidis. (2008) Statins and Heart Failure. Angiology 59:2_suppl, pages 58S-61S.
Crossref
Crossref
Sofia G. Tsouli, Evangelos N. Liberopoulos, John A. Goudevenos, Dimitri P. Mikhailidis & Moses S. Elisaf. (2007) Should a statin be prescribed to every patient with heart failure?. Heart Failure Reviews 13:2, pages 211-225.
Crossref
Crossref
Kosmas I. Paraskevas, Christos D. Liapis, George Hamilton & Dimitri P. Mikhailidis. (2008) Are Statins an Option in the Management of Abdominal Aortic Aneurysms?. Vascular and Endovascular Surgery 42:2, pages 128-134.
Crossref
Crossref
Minoru Hongo, Hiroshi Tsutsui, Eiichiro Mawatari, Hiroya Hidaka, Setsuo Kumazaki, Yoshikazu Yazaki, Masafumi Takahashi, Osamu Kinoshita & Uichi Ikeda. (2008) Fluvastatin Improves Arterial Stiffness in Patients With Coronary Artery Disease and Hyperlipidemia. Circulation Journal 72:5, pages 722-728.
Crossref
Crossref
Michael S. Kostapanos, Christos S. Derdemezis, Theodosios D. Filippatos, Haralampos J. Milionis, Dimitrios N. Kiortsis, Alexandros D. Tselepis & Moses S. Elisaf. (2008) Effect of rosuvastatin treatment on plasma visfatin levels in patients with primary hyperlipidemia. European Journal of Pharmacology 578:2-3, pages 249-252.
Crossref
Crossref
Efstathios PapalambrosFragiska Sigala, Sotiris Georgopoulos, Kosmas I. Paraskevas, Ioanna Andreadou, Xaralambos Menenakos, Panagiotis Sigalas, Alexandros L. Papalambros, Georgios Vourliotakis, Athanasios Giannopoulos, Christos Bakoyiannis & Elias Bastounis. (2016) Malondialdehyde as an Indicator of Oxidative Stress During Abdominal Aortic Aneurysm Repair. Angiology 58:4, pages 477-482.
Crossref
Crossref
Kosmas I. Paraskevas, George Hamilton & Dimitri P. Mikhailidis. (2007) Statins: An essential component in the management of carotid artery disease. Journal of Vascular Surgery 46:2, pages 373-386.e9.
Crossref
Crossref
Surya P. Ayalasomayajula, Sujata Vaidyanathan, Charisse Kemp, Pratapa Prasad, Alfred Balch & William P. Dole. (2007) Effect of Clopidogrel on the Steady-State Pharmacokinetics of Fluvastatin. The Journal of Clinical Pharmacology 47:5, pages 613-619.
Crossref
Crossref
Dimitrios S. Christidis, Evangelos N. Liberopoulos, Anna I. Kakafika, George A. Miltiadous, George L. Liamis, Barbara Kakaidi, Alexandros D. Tselepis, Marios A. Cariolou & Moses S. Elisaf. (2007) Effect of Paraoxonase 1 Polymorphisms on the Response of Lipids and Lipoprotein-associated Enzymes to Treatment with Fluvastatin. Archives of Medical Research 38:4, pages 403-410.
Crossref
Crossref
Savaş Demirbilek, Erkan Tas, Kubilay Gurunluoglu, Melih Akin, Rauf T. Aksoy, Memet H. Emre, Nasuhi E. Aydin, Selma Ay & Nilufer Ozatay. (2006) Fluvastatin reduced liver injury in rat model of extrahepatic cholestasis. Pediatric Surgery International 23:2, pages 155-162.
Crossref
Crossref
Evangelos Liberopoulos & Dimitri Mikhailidis. 2006. Case Studies in Lipid Management. Case Studies in Lipid Management
175
178
.
H J Milionis, E N Liberopoulos, A Achimastos, M S Elisaf & D P Mikhailidis. (2006) Statins: another class of antihypertensive agents?. Journal of Human Hypertension 20:5, pages 320-335.
Crossref
Crossref
Evagelos N. Liberopoulos & Dimitris P. Mikhailidis. (2006) Could Statins Be Useful in the Treatment of Patients With Migraine?. Headache: The Journal of Head and Face Pain 46:4, pages 672-675.
Crossref
Crossref
E. N. Liberopoulos, D. P. Mikhailidis & M. S. Elisaf. (2005) Diagnosis and management of the metabolic syndrome in obesity. Obesity Reviews 6:4, pages 283-296.
Crossref
Crossref